期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Recent advances of traditional Chinese medicine on the prevention and treatment of COVID-19 被引量:13
1
作者 DAI Yu-Jie WAN Shi-Yao +3 位作者 GONG Shuai-Shuai LIU Jin-Cheng LI Fang KOU Jun-Ping 《Chinese Journal of Natural Medicines》 SCIE CAS CSCD 2020年第12期881-889,共9页
Coronavirus disease-2019(COVID-19)is a new highly infectious disease caused by a novel coronavirus.Recently,the number of new cases infected pneumonia in the world continues to increase,which has aroused great concern... Coronavirus disease-2019(COVID-19)is a new highly infectious disease caused by a novel coronavirus.Recently,the number of new cases infected pneumonia in the world continues to increase,which has aroused great concern from the international community.At present,there are no small-molecule specific anti-viral drugs for the treatment.The high mortality rate seriously threatens human health.Traditional Chinese medicine(TCM)is a unique health resource in China.The combination of TCM and Western medicine has played a positive and important role in combating COVID-19 in China.In this review,through literature mining and analysis,it was found that TCM has the potential to prevent and treat the COVID-19.Then,the network pharmacological studies demonstrated that TCM played roles of anti-virus,anti-inflammation and immunoregulation in the management of COVID-19 via multiple components acting on multiple targets and multiple pathways.Finally,clinical researches also confirmed the beneficial effects of TCM on the treatment of patients.This review may provide meaningful and useful information on further drug development of COVID-19 and other viral infectious diseases. 展开更多
关键词 Novel coronavirus pneumonia Prescription of traditional chinese medicine Single chinese herb Active ingredients of traditional chinese medicine Viral infection
原文传递
Letter to the editor: Comment on the Regulatios of the Simplified Registration and Approval Management for Compound Recipe of Classical Prescription of Traditional Chinese Medicine 被引量:1
2
作者 Shilin Chen Aihua Liang Boli Zhang 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2018年第1期127-129,共3页
To the Editor:On Oct 9,2017,China Food and Drug Administration announced1~ the Regulations of the Simplified Registration and Approval Management for Compound Recipe of Classical Prescription of Traditional Chinese Me... To the Editor:On Oct 9,2017,China Food and Drug Administration announced1~ the Regulations of the Simplified Registration and Approval Management for Compound Recipe of Classical Prescription of Traditional Chinese Medicine(Exposure Draft)which has been stirring up intense debate in the West.The article China to Roll Back Regulations for Traditional Medicine Despite Safety Concerns lately 展开更多
关键词 In Letter to the editor Comment on the Regulatios of the Simplified Registration and Approval Management for Compound Recipe of Classical Prescription of traditional chinese medicine
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部